Online-Only ArticlePalliative Care in the New Era of Lung Cancer TreatmentBorneman, Tami RN, MSN, CNS, FPCN; Koczywas, Marianna MD Author Information Tami Borneman, RN, MSN, CNS, FPCN, is senior research specialist, Division of Nursing Research and Education, City of Hope National Medical Center, Duarte, CA. Marianna Koczywas, MD, is medical oncologist, Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA. Address correspondence to Tami Borneman, RN, MSN, CNS, FPCN, City of Hope National Medical Center, Department of Population Sciences, Division of Nursing Research and Education, 1500 East Duarte Rd, Duarte, CA 91010 ([email protected]). The authors have no conflicts of interest to disclose. Journal of Hospice & Palliative Nursing 25(3):p E58-E63, June 2023. | DOI: 10.1097/NJH.0000000000000945 Buy CME Test Metrics Abstract Lung cancer remains the most common malignancy and is recognized as having significant impact on quality of life. Advances in lung cancer treatment over the past decade have been significant, with new agents extending life, even in late-stage disease. The purpose of this study was to evaluate palliative care needs and use of supportive care services in a randomly selected sample (N = 99) of patients with lung cancer. Results indicated that despite treatment advances, these patients continue to have significant symptom and quality of life concerns and to receive limited palliative care or supportive care services. Integration of palliative care is needed in the new era of lung cancer treatment. Copyright © 2023 by The Hospice and Palliative Nurses Association. All rights reserved.